https://als-research.org/publication/baseline-and-longitudinal-volumetric-changes-associated-with-presymptomatic-c9orf72-repeat-expansion-carriers/2022-03-25T21:13:32+00:00https://als-research.org/publication/when-does-als-begin-insights-from-serum-and-csf-neurofilament-light-and-heavy/2022-03-25T21:13:32+00:00https://als-research.org/publication/biomarkers-for-als-therapy-development/2022-03-25T21:13:32+00:00https://als-research.org/publication/symptomatic-and-pre-symptomatic-biomarkers-for-als-therapy-development/2022-03-25T21:13:32+00:00https://als-research.org/publication/als-therapy-development/2022-03-25T21:13:32+00:00https://als-research.org/publication/conceptual-framework-and-strategies-for-studying-pre-symptomatic-als/2022-03-25T21:13:32+00:00https://als-research.org/publication/biomarkers-for-als-therapy-development-2/2022-03-25T21:13:35+00:00https://als-research.org/publication/biomarker-validation/2022-03-25T21:13:35+00:00https://als-research.org/publication/als-therapy-development-challenges-and-opportunities/2022-03-25T21:13:35+00:00https://als-research.org/publication/lessons-for-charcot-marie-tooth-cmt-clinical-trials-from-als-experience/2022-03-25T21:13:35+00:00https://als-research.org/publication/challenges-and-opportunities-in-als-therapy-development/2022-03-25T21:13:35+00:00https://als-research.org/publication/genetic-advances-in-als-insights-and-implications/2022-03-25T21:13:35+00:00https://als-research.org/publication/pre-symptomatic-loss-of-cerebral-white-matter-integrity-in-those-at-genetic-risk-of-amyotrophic-lateral-sclerosis/2022-03-25T21:13:35+00:00https://als-research.org/publication/year-in-review-als/2022-03-25T21:13:35+00:00https://als-research.org/publication/pre-symptomatic-studies-in-als-rationale-challenges-and-approach/2022-03-25T21:13:35+00:00https://als-research.org/publication/pre-fals-pre-symptomatic-studies-in-als/2022-03-25T21:13:35+00:00https://als-research.org/publication/identifying-biomarkers-in-familial-als/2022-03-25T21:13:35+00:00https://als-research.org/publication/piecing-together-the-puzzle-of-als-an-emerging-picture/2022-03-25T21:13:35+00:00https://als-research.org/publication/animal-models-in-als-the-good-the-bad-and-the-ugly/2022-03-25T21:13:35+00:00https://als-research.org/publication/tackling-the-challenges-of-als-a-familial-perspective/2022-03-25T21:13:35+00:00https://als-research.org/publication/methodological-issues-in-animal-therapeutic-studies-lessons-from-other-neurological-diseases/2022-03-25T21:13:35+00:00https://als-research.org/publication/electrical-impedance-myography-eim-findings-in-pre-symptomatic-sod1-subjects/2022-03-25T21:13:35+00:00https://als-research.org/publication/the-limitations-of-animal-models-of-neurodegenerative-disease/2022-03-25T21:13:35+00:00https://als-research.org/publication/randomized-placebo-controlled-trial-of-arimoclomol-in-sod1-positive-familial-als/2022-03-25T21:13:37+00:00https://als-research.org/publication/phase-ii-iii-randomized-placebo-controlled-trial-of-arimoclomol-in-sod1-positive-familial-als/2022-03-25T21:13:37+00:00https://als-research.org/publication/panel-discussant-on-the-topic-of-animal-models-for-neurological-disease-success-or-lack-of-success-for-translation/2022-03-25T21:13:37+00:00https://als-research.org/publication/multisystem-proteinopathy-implications-for-als-mnd/2022-03-25T21:13:37+00:00https://als-research.org/publication/lessons-for-huntingtons-disease-from-amyotrophic-lateral-sclerosis/2022-03-25T21:13:37+00:00https://als-research.org/publication/piecing-together-the-puzzle-of-als-an-emerging-picture-2/2022-03-25T21:13:37+00:00https://als-research.org/publication/harnessing-the-power-of-the-electronic-health-record-for-als-research-and-quality-improvement-create-capture-als-and-the-als-toolkit/2022-04-22T16:51:15+00:00https://als-research.org/publication/preventing-amyotrophic-lateral-sclerosis-insights-from-pre-symptomatic-neurodegenerative-diseases/2025-12-17T19:19:42+00:00https://als-research.org/publication/humoral-response-to-neurofilaments-and-dipeptide-repeats-in-als-progression/2024-11-22T18:59:47+00:00https://als-research.org/publication/repeats-expansions-in-atxn2-nop56-nipa1-and-atxn1-are-not-associated-with-als-in-africans/2022-04-22T16:51:15+00:00https://als-research.org/publication/fgf23-a-novel-muscle-biomarker-detected-in-the-early-stages-of-als/2022-04-22T16:51:15+00:00https://als-research.org/publication/application-of-a-bioinformatic-pipeline-to-rna-seq-data-identifies-novel-viruslike-sequence-in-human-blood/2025-12-17T19:18:23+00:00https://als-research.org/publication/challenges-and-opportunities-for-multi-national-investigator-initiated-clinical-trials-for-als-european-and-united-states-collaborations/2022-04-22T16:51:16+00:00https://als-research.org/publication/preface-promoting-research-in-pls-current-knowledge-and-future-challenges/2025-12-17T19:17:35+00:00https://als-research.org/publication/machine-learning-suggests-polygenic-risk-for-cognitive-dysfunction-in-amyotrophic-lateral-sclerosis/2024-11-22T19:01:22+00:00https://als-research.org/publication/incremental-gains-in-the-battle-against-als/2025-12-17T19:17:10+00:00https://als-research.org/publication/csf-chitinases-before-and-after-symptom-onset-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:16+00:00https://als-research.org/publication/validation-of-serum-neurofilaments-as-prognostic-and-potential-pharmacodynamic-biomarkers-for-als/2022-04-22T16:51:16+00:00https://als-research.org/publication/dipeptide-repeat-proteins-inhibit-homology-directed-dna-double-strand-break-repair-in-c9orf72-als-ftd/2022-04-22T16:51:16+00:00https://als-research.org/publication/primary-lateral-sclerosis-consensus-diagnostic-criteria/2025-12-17T19:16:52+00:00https://als-research.org/publication/exome-sequencing-in-amyotrophic-lateral-sclerosis-implicates-a-novel-gene-dnajc7-encoding-a-heat-shock-protein/2022-04-22T16:51:16+00:00https://als-research.org/publication/pediatric-cancer-variant-pathogenicity-information-exchange-pecanpie-a-cloud-based-platform-for-curating-and-classifying-germline-variants/2022-04-22T16:51:16+00:00https://als-research.org/publication/neurofilaments-in-pre-symptomatic-als-and-the-impact-of-genotype/2022-04-22T16:51:16+00:00https://als-research.org/publication/an-endogenous-peptide-marker-differentiates-sod1-stability-and-facilitates-pharmacodynamic-monitoring-in-sod1-amyotrophic-lateral-sclerosis/2022-04-22T16:51:16+00:00https://als-research.org/publication/a-phase-iii-trial-of-tirasemtiv-as-a-potential-treatment-for-amyotrophic-lateral-sclerosis/2022-04-22T16:51:16+00:00https://als-research.org/publication/rock-als-protocol-for-a-randomized-placebo-controlled-double-blind-phase-iia-trial-of-safety-tolerability-and-efficacy-of-the-rho-kinase-rock-inhibitor-fasudil-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:16+00:00https://als-research.org/publication/defining-pre-symptomatic-amyotrophic-lateral-sclerosis/2025-12-17T19:14:34+00:00https://als-research.org/publication/revised-airlie-house-consensus-guidelines-for-design-and-implementation-of-als-clinical-trials/2025-12-17T19:14:11+00:00https://als-research.org/publication/reducing-sample-size-requirements-for-future-als-clinical-trials-with-a-dedicated-electrical-impedance-myography-system/2022-04-22T16:51:18+00:00https://als-research.org/publication/neurofilament-light-a-candidate-biomarker-of-presymptomatic-amyotrophic-lateral-sclerosis-and-phenoconversion/2022-04-22T16:51:18+00:00https://als-research.org/publication/impaired-corticomuscular-and-interhemispheric-cortical-beta-oscillation-coupling-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:18+00:00https://als-research.org/publication/increased-cerebral-functional-connectivity-in-als-a-resting-state-magnetoencephalography-study/2022-04-22T16:51:18+00:00https://als-research.org/publication/genome-wide-analyses-identify-kif5a-as-a-novel-als-gene/2022-04-22T16:51:18+00:00https://als-research.org/publication/identification-of-compound-heterozygous-variants-in-optn-in-an-als-ftd-patient-from-the-create-consortium-a-case-report/2022-04-22T16:51:18+00:00https://als-research.org/publication/randomized-double-blind-placebo-controlled-trial-of-arimoclomol-in-rapidly-progressive-sod1-als/2022-04-22T16:51:18+00:00https://als-research.org/publication/abnormal-expression-of-homeobox-genes-and-transthyretin-in-c9orf72-expansion-carriers/2022-04-22T16:51:18+00:00https://als-research.org/publication/phosphorylated-neurofilament-heavy-chain-a-biomarker-of-survival-for-c9orf72-associated-amyotrophic-lateral-sclerosis/2022-04-22T16:51:18+00:00https://als-research.org/publication/a-c9orf72-bac-mouse-model-recapitulates-key-epigenetic-perturbations-of-als-ftd/2022-04-22T16:51:18+00:00https://als-research.org/publication/polygp-proteins-are-a-useful-pharmacodynamic-marker-for-c9orf72-associated-amyotrophic-lateral-sclerosis/2022-04-22T16:51:18+00:00https://als-research.org/publication/urinary-p75ecd-a-prognostic-disease-progression-and-pharmacodynamic-biomarker-in-als/2022-04-22T16:51:18+00:00https://als-research.org/publication/amyotrophic-lateral-sclerosis-frontotemporal-spectrum-disorder-als-ftsd-revised-diagnostic-criteria/2025-12-17T19:13:25+00:00https://als-research.org/publication/sequence-variations-in-c9orf72-downstream-of-the-hexanucleotide-repeat-region-and-its-effect-on-repeat-primed-pcr-interpretation-a-large-multinational-screening-study/2022-04-22T16:51:18+00:00https://als-research.org/publication/altered-cortical-beta-band-oscillations-reflect-motor-system-degeneration-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:19+00:00https://als-research.org/publication/presymptomatic-als-genetic-counseling-and-testing-experience-and-recommendations/2025-12-17T19:12:28+00:00https://als-research.org/publication/c9orf72-promoter-hypermethylation-is-reduced-while-hydroxymethylation-is-acquired-during-reprogramming-of-als-patient-cells/2022-04-22T16:51:19+00:00https://als-research.org/publication/increased-functional-connectivity-common-to-symptomatic-amyotrophic-lateral-sclerosis-and-those-at-genetic-risk/2022-04-22T16:51:19+00:00https://als-research.org/publication/als-biomarkers-for-therapy-development-state-of-the-field-and-future-directions/2025-12-17T19:11:12+00:00https://als-research.org/publication/mind-the-gap-the-mismatch-between-clinical-and-imaging-metrics-in-als/2025-12-17T19:10:32+00:00https://als-research.org/publication/progress-towards-a-neuroimaging-biomarker-for-amyotrophic-lateral-sclerosis/2025-12-17T19:10:49+00:00https://als-research.org/publication/bromodomain-inhibitors-regulate-the-c9orf72-locus-in-als/2022-04-22T16:51:20+00:00https://als-research.org/publication/novel-mutations-expand-the-clinical-spectrum-of-dync1h1-associated-spinal-muscular-atrophy/2022-04-22T16:51:20+00:00https://als-research.org/publication/ensuring-continued-progress-in-biomarkers-for-amyotrophic-lateral-sclerosis/2025-12-17T19:09:44+00:00https://als-research.org/publication/a-case-of-familial-als-due-to-multi-system-proteinopathy-1-and-huntington-disease/2022-04-22T16:51:20+00:00https://als-research.org/publication/electrical-impedance-myography-correlates-with-standard-measures-of-als-severity/2022-04-22T16:51:20+00:00https://als-research.org/publication/diagnostic-accuracy-of-diffusion-tensor-imaging-in-amyotrophic-lateral-sclerosis-a-systematic-review-and-individual-patient-data-meta-analysis/2022-04-22T16:51:20+00:00https://als-research.org/publication/motor-neuron-involvement-in-multisystem-proteinopathy-implications-for-als/2022-04-22T16:51:20+00:00https://als-research.org/publication/opportunity-and-innovation-in-studying-pre-symptomatic-amyotrophic-lateral-sclerosis/2025-12-17T19:08:46+00:00https://als-research.org/publication/mutations-in-prion-like-domains-in-hnrnpa2b1-and-hnrnpa1-cause-multisystem-proteinopathy-and-als/2022-04-22T16:51:21+00:00https://als-research.org/publication/controversies-and-priorities-in-amyotrophic-lateral-sclerosis/2025-12-17T19:07:48+00:00https://als-research.org/publication/utility-of-capture-recapture-methodology-to-assess-completeness-of-amyotrophic-lateral-sclerosis-case-ascertainment/2022-04-22T16:51:21+00:00https://als-research.org/publication/presymptomatic-studies-in-als-rationale-challenges-and-approach/2025-12-17T19:07:32+00:00https://als-research.org/publication/electrical-impedance-myography-as-a-biomarker-to-assess-als-progression/2022-04-22T16:51:21+00:00https://als-research.org/publication/valosin-containing-protein-vcp-mutations-in-sporadic-amyotrophic-lateral-sclerosis/2022-04-22T16:51:21+00:00https://als-research.org/publication/a-hexanucleotide-repeat-expansion-in-c9orf72-is-the-cause-of-chromosome-9p21-linked-als-ftd/2022-04-22T16:51:21+00:00https://als-research.org/publication/presymptomatic-spinal-cord-neurometabolic-findings-in-sod1-positive-people-at-risk-for-familial-als/2022-04-22T16:51:21+00:00https://als-research.org/publication/multipoint-incremental-motor-unit-number-estimation-as-an-outcome-measure-in-als/2022-04-22T16:51:21+00:00https://als-research.org/publication/towards-a-neuroimaging-biomarker-for-amyotrophic-lateral-sclerosis/2025-12-17T19:06:07+00:00https://als-research.org/publication/the-awaji-criteria-for-the-diagnosis-of-amyotrophic-lateral-sclerosis-have-we-put-the-cart-before-the-horse/2025-12-17T19:05:26+00:00https://als-research.org/publication/impact-of-presymptomatic-genetic-testing-for-familial-amyotrophic-lateral-sclerosis/2022-04-22T16:51:22+00:00https://als-research.org/publication/enteral-tube-feeding-for-amyotrophic-lateral-sclerosis-motor-neuron-disease/2022-04-22T16:51:22+00:00https://als-research.org/publication/magnetic-resonance-spectroscopy-of-the-cervical-cord-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:22+00:00https://als-research.org/publication/preparing-for-a-u-s-national-als-registry-lessons-from-a-pilot-project-in-the-state-of-georgia/2022-04-22T16:51:22+00:00https://als-research.org/publication/exome-sequencing-reveals-vcp-mutations-as-a-cause-of-familial-als/2022-04-22T16:51:22+00:00https://als-research.org/publication/diffusion-tensor-imaging-reveals-regional-differences-in-the-cervical-spinal-cord-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:23+00:00https://als-research.org/publication/utility-of-axial-and-radial-diffusivity-from-diffusion-tensor-mri-as-markers-of-neurodegeneration-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:23+00:00https://als-research.org/publication/treatment-for-familial-amyotrophic-lateral-sclerosis-motor-neuron-disease/2025-12-17T19:05:00+00:00https://als-research.org/publication/neuroscience-standard-model/2025-12-17T19:03:14+00:00https://als-research.org/publication/clinical-electrophysiologic-and-pathologic-evidence-for-sensory-abnormalities-in-als/2022-04-22T16:51:23+00:00https://als-research.org/publication/what-zebras-and-mice-can-teach-us-about-familial-als/2025-12-17T18:56:40+00:00https://als-research.org/publication/diagnostic-accuracy-of-thoracic-paraspinal-electromyography-in-amyotrophic-lateral-sclerosis/2022-04-22T16:51:23+00:00https://als-research.org/publication/lost-in-translation-treatment-trials-in-the-sod1-mouse-and-in-human-als/2025-12-17T19:01:32+00:00https://als-research.org/publication/the-electromyographic-diagnosis-of-amyotrophic-lateral-sclerosis-does-the-evidence-support-the-el-escorial-criteria/2022-04-22T16:51:23+00:00https://als-research.org/publication/preventing-familial-amyotrophic-lateral-sclerosis-is-a-clinical-trial-feasible/2022-04-22T16:51:23+00:00https://als-research.org/publication/genotype-phenotype-correlation-and-longitudinal-study-of-hereditary-spastic-paraplegia-and-primary-lateral-sclerosis-3/2022-06-01T18:22:30+00:00https://als-research.org/publication/chitotriosidase-level-and-activity-rises-in-the-pre-and-early-symptomatic-phases-of-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/blood-and-csf-neurofilament-levels-as-biomarkers-of-pre-symptomatic-disease-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/urinary-p75-neurotrophin-receptor-extracellular-domain-a-biomarker-relevant-to-als-therapy-development-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/randomized-phase-ii-trial-of-arimoclomol-in-rapidly-progressive-sod1-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/quantitative-motor-testing-biomarker-of-pre-symptomatic-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/pre-symptomatic-als-genetic-counseling-and-testing-experience-and-recommendations-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/the-challenge-of-early-therapeutic-intervention-in-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/motor-neuron-involvement-in-multi-system-proteinopathy-implications-for-als-mnd-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/mri-evidence-of-disease-in-pre-symptomatic-sod1-individuals-at-risk-for-developing-familial-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/telemedicine-to-facilitate-als-research-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/tackling-the-challenges-of-als-from-a-familial-perspective-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/design-of-a-phase-3-randomized-placebo-controlled-trial-of-tofersen-initiated-in-clinically-presymptomatic-sod1-mutation-carriers-the-atlas-study-2/2023-11-08T16:07:30+00:00https://als-research.org/publication/frequency-hazard-and-genetic-risk-factors-of-cognitive-impairment-in-amyotrophic-lateral-sclerosis-als-2/2022-06-01T18:22:30+00:00https://als-research.org/publication/predictive-preventive-and-therapeutic-studies-in-familial-als-2/2022-06-01T18:22:34+00:00https://als-research.org/publication/strategies-for-pre-symptomatic-biomarker-identification-in-familial-als-2/2022-06-01T18:22:34+00:00https://als-research.org/publication/epigenetic-small-molecules-rescue-nucleocytoplasmic-transport-and-dna-damage-phenotypes-in-c9orf72-als-ftd/2022-07-21T18:12:30+00:00https://als-research.org/publication/adaptive-platform-trials-to-transform-amyotrophic-lateral-sclerosis-therapy-development/2022-07-21T18:24:36+00:00https://als-research.org/publication/urinary-neopterin-a-novel-biomarker-of-disease-progression-in-amyotrophic-lateral-sclerosis/2022-07-21T19:07:37+00:00https://als-research.org/publication/revealing-the-mutational-spectrum-in-southern-africans-with-amyotrophic-lateral-sclerosis/2022-07-21T19:05:31+00:00https://als-research.org/publication/phase-2b-randomized-controlled-trial-of-np001-in-amyotrophic-lateral-sclerosis-pre-specified-and-post-hoc-analyses/2022-07-21T19:24:39+00:00https://als-research.org/publication/defining-cognitive-impairment-in-amyotrophic-lateral-sclerosis-an-evaluation-of-empirical-approaches/2025-11-25T16:32:12+00:00https://als-research.org/publication/occupational-lead-exposure-and-survival-with-amyotrophic-lateral-sclerosis/2024-11-22T18:51:51+00:00https://als-research.org/publication/pre-symptomatic-spinal-muscular-atrophy-a-proposed-nosology/2025-12-17T19:22:00+00:00https://als-research.org/publication/design-of-a-randomized-placebo-controlled-phase-3-trial-of-tofersen-initiated-in-clinically-presymptomatic-sod1-variant-carriers-the-atlas-study/2024-11-22T18:42:28+00:00https://als-research.org/publication/mild-motor-impairment-as-prodromal-state-in-amyotrophic-lateral-sclerosis-a-new-diagnostic-entity/2024-11-22T18:41:19+00:00https://als-research.org/publication/functional-alterations-in-large-scale-resting-state-networks-of-amyotrophic-lateral-sclerosis-a-multi-site-study-across-canada-and-the-united-states/2022-08-01T15:06:18+00:00https://als-research.org/publication/trial-of-antisense-oligonucleotide-tofersen-for-sod1-als/2022-11-23T21:17:51+00:00https://als-research.org/publication/neurofilament-light-chain-in-drug-development-for-amyotrophic-lateral-sclerosis-a-critical-appraisal/2025-12-17T19:24:09+00:00https://als-research.org/publication/research-update/2022-12-05T20:06:17+00:00https://als-research.org/publication/pre-symptomatic-familial-als-the-long-view-to-disease-prevention/2022-12-05T20:06:54+00:00https://als-research.org/publication/does-cognition-and-behaviour-change-over-time-in-als-2/2022-12-05T20:05:45+00:00https://als-research.org/publication/challenging-dogma-and-changing-paradigms-in-als-therapy-development/2022-12-05T20:09:33+00:00https://als-research.org/publication/pre-symptomatic-als-from-natural-history-to-early-intervention-and-beyond/2022-12-05T20:10:57+00:00https://als-research.org/publication/pre-symptomatic-and-symptomatic-biomarkers-for-als-therapy-development/2022-12-05T20:13:41+00:00https://als-research.org/publication/mild-motor-impairment-as-prodromal-state-in-als/2022-12-05T20:34:51+00:00https://als-research.org/publication/treatment-and-prevention-from-genetic-to-all-als/2022-12-05T20:37:21+00:00https://als-research.org/publication/5992/2022-12-06T20:26:25+00:00https://als-research.org/publication/the-atlas-study-2/2022-12-06T20:29:53+00:00https://als-research.org/publication/characterizing-pre-symptomatic-als-to-identify-opportunities-for-early-therapeutic-intervention/2022-12-06T20:34:55+00:00https://als-research.org/publication/pinpointing-phenoconversion/2022-12-06T20:36:52+00:00https://als-research.org/publication/pre-symptomatic-mild-cognitive-and-behaviour-impairment-in-als-frontotemporal-spectrum-disorder-als-ftsd-a-conceptual-framework/2022-12-06T20:53:20+00:00https://als-research.org/publication/progress-towards-als-prevention/2022-12-06T21:02:54+00:00https://als-research.org/publication/rethinking-als-prodrome-biomarkers-disease-prevention-4/2022-12-06T21:05:32+00:00https://als-research.org/publication/evolving-paradigms-in-als-therapy-development/2022-12-06T21:07:40+00:00https://als-research.org/publication/the-atlas-study-rationale-and-design-of-a-phase-3-randomized-placebo-controlled-trial-of-tofersen-initiated-in-clinically-presymptomatic-sod1-mutation-carriers-2/2022-12-06T21:10:19+00:00https://als-research.org/publication/patterns-of-longitudinal-cognitive-and-behavioural-changes-in-als-mnd/2022-12-28T16:47:58+00:00https://als-research.org/publication/mild-motor-impairment-and-prodromal-disease-markers/2022-12-28T16:50:14+00:00https://als-research.org/publication/defining-mild-cognitive-and-behavioural-impairment-in-pre-symptomatic-als-ftd/2022-12-28T16:51:38+00:00https://als-research.org/publication/patient-reported-impact-of-symptoms-in-amyotrophic-lateral-sclerosis-prism-als-a-national-cross-sectional-study/2023-10-31T15:34:30+00:00https://als-research.org/publication/a-roadmap-to-als-prevention-strategies-and-priorities/2025-12-17T19:26:13+00:00https://als-research.org/publication/analysis-of-structural-variants-previously-associated-with-als-in-europeans-highlights-genomic-architectural-differences-in-africans/2023-10-31T19:44:56+00:00https://als-research.org/publication/the-amyotrophic-lateral-sclerosis-health-index-als-hi-development-and-evaluation-of-a-novel-outcome-measure/2024-11-22T18:38:35+00:00https://als-research.org/publication/reply-a-new-diagnostic-entity-must-enable-earlier-treatment-in-gene-carriers/2025-12-17T19:26:04+00:00https://als-research.org/publication/pre-symptomatic-amyotrophic-lateral-sclerosis-from-characterization-to-prevention/2025-12-17T19:29:00+00:00https://als-research.org/publication/als-therapy-development-challenges-and-opportunities-2/2023-11-08T16:37:16+00:00https://als-research.org/publication/challenges-and-opportunities-in-als-therapy-development-2/2023-11-08T16:37:08+00:00https://als-research.org/publication/challenges-and-opportunities-in-als-therapy-development-3/2023-11-08T16:36:58+00:00https://als-research.org/publication/rethinking-als-prodrome-biomarkers-disease-prevention/2023-11-08T16:36:42+00:00https://als-research.org/publication/the-atlas-study/2023-11-08T16:36:33+00:00https://als-research.org/publication/rethinking-als-prodrome-biomarkers-disease-prevention-2/2023-11-08T16:36:25+00:00https://als-research.org/publication/rethinking-als-prodrome-biomarkers-disease-prevention-3/2023-11-08T16:36:10+00:00https://als-research.org/publication/the-atlas-study-rationale-and-design-of-a-phase-3-randomized-placebo-controlled-trial-of-tofersen-initiated-in-clinically-presymptomatic-sod1-mutation-carriers/2023-11-08T16:35:59+00:00https://als-research.org/publication/roadmap-for-c9orf72-in-frontotemporal-dementia-and-amyotrophic-lateral-sclerosis-report-on-the-c9orf72-ftd-als-summit/2025-12-17T19:28:54+00:00https://als-research.org/publication/the-temporal-course-of-cognitive-and-behavioural-changes-in-motor-neuron-diseases/2024-11-22T17:18:33+00:00https://als-research.org/publication/biomarker-qualification-for-neurofilament-light-chain-in-als-theory-and-practice/2025-12-17T19:29:56+00:00https://als-research.org/publication/the-miami-framework-for-als-and-related-neurodegenerative-disorders-an-integrated-view-of-phenotype-and-biology/2025-12-17T19:31:07+00:00https://als-research.org/publication/safety-and-efficacy-of-arimoclomol-in-patients-with-early-amyotrophic-lateral-sclerosis-orarials-01-a-randomised-double-blind-placebo-controlled-multicentre-phase-3-trial/2024-11-22T17:09:51+00:00https://als-research.org/publication/genetic-associations-with-an-amyotrophic-lateral-sclerosis-reversal-phenotype/2025-12-17T19:36:39+00:00https://als-research.org/publication/prognostic-clinical-and-biological-markers-for-amyotrophic-lateral-sclerosis-disease-progression-validation-and-implications-for-clinical-trial-design-and-analysis/2025-12-17T19:35:52+00:00https://als-research.org/publication/body-mass-index-is-lower-in-asymptomatic-c9orf72-expansion-carriers-but-not-in-sod1-pathogenic-variant-carriers-compared-to-gene-negatives/2025-12-17T19:35:34+00:00https://als-research.org/publication/safety-tolerability-and-efficacy-of-fasudil-in-amyotrophic-lateral-sclerosis-rock-als-a-phase-2-randomised-double-blind-placebo-controlled-trial/2025-12-17T19:35:17+00:00https://als-research.org/publication/crispr-cas9-mediated-excision-of-als-ftd-causing-hexanucleotide-repeat-expansion-in-c9orf72-rescues-major-disease-mechanisms-in-vivo-and-in-vitro/2025-12-17T19:37:13+00:00https://als-research.org/publication/amyotrophic-lateral-sclerosis-quality-measurement-set-2022-update-quality-improvement-in-neurology/2025-12-02T20:50:28+00:00https://als-research.org/publication/amyotrophic-lateral-sclerosis-spectrum-disorders-gene-curation-expert-panel-clinical-testing-panels-for-als-global-distribution-consistency-and-challenges/2025-12-02T20:53:28+00:00https://als-research.org/publication/the-mutational-profile-in-a-south-african-cohort-with-inherited-neuropathies-and-spastic-paraplegia/2025-12-02T20:56:34+00:00https://als-research.org/publication/sf2former-amyotrophic-lateral-sclerosis-identification-from-multi-center-mri-data-using-spatial-and-frequency-fusion-transformer/2025-12-02T20:59:45+00:00https://als-research.org/publication/mismatch-between-clinically-defined-classification-of-als-stage-and-the-burden-of-cerebral-pathology/2025-12-02T21:01:55+00:00https://als-research.org/publication/temporal-and-spatial-progression-of-microstructural-cerebral-degeneration-in-als-a-multicentre-longitudinal-diffusion-tensor-imaging-study/2025-12-17T19:36:56+00:00https://als-research.org/publication/safety-tolerability-and-pharmacokinetics-of-antisense-oligonucleotide-biib078-in-adults-with-c9orf72-associated-amyotrophic-lateral-sclerosis-a-phase-1-randomised-double-blinded-placebo-controll/2025-12-17T19:55:37+00:00https://als-research.org/publication/the-basis-of-cognitive-and-behavioral-dysfunction-in-amyotrophic-lateral-sclerosis/2025-12-19T13:50:38+00:00https://als-research.org/publication/guidance-for-clinical-management-of-pathogenic-variant-carriers-at-elevated-genetic-risk-for-als-ftd/2025-12-19T13:42:59+00:00https://als-research.org/publication/rethinking-phase-2-trials-in-amyotrophic-lateral-sclerosis/2025-12-19T13:49:05+00:00https://als-research.org/publication/patrikios-syndrome-and-sod1-als/2025-12-19T13:58:18+00:00https://als-research.org/publication/amyotrophic-lateral-sclerosis-caused-by-sod1-variants-from-genetic-discovery-to-disease-prevention/2025-12-19T14:00:21+00:00https://als-research.org/publication/reply-overstating-harms-can-have-consequences/2025-12-19T14:03:11+00:00https://als-research.org/publication/efficacy-and-safety-of-zilucoplan-in-amyotrophic-lateral-sclerosis-a-randomized-clinical-trial/2025-12-19T14:08:18+00:00https://als-research.org/publication/an-observational-study-of-pleiotropy-and-penetrance-of-amyotrophic-lateral-sclerosis-associated-with-cag-repeat-expansion-of-atxn2/2025-12-19T14:05:23+00:00https://als-research.org/publication/verdiperstat-in-amyotrophic-lateral-sclerosis-results-from-the-randomized-healey-als-platform-trial/2025-12-19T14:10:32+00:00https://als-research.org/publication/pridopidine-in-amyotrophic-lateral-sclerosis-the-healey-als-platform-trial/2025-12-19T14:15:01+00:00https://als-research.org/publication/cnm-au8-in-amyotrophic-lateral-sclerosis-the-healey-als-platform-trial/2025-12-19T14:18:17+00:00https://als-research.org/publication/examining-the-evidence-for-il-2-in-amyotrophic-lateral-sclerosis/2025-12-19T14:20:14+00:00https://als-research.org/publication/extreme-exercise-in-males-is-linked-to-mtor-signalling-and-onset-of-amyotrophic-lateral-sclerosis/2025-12-19T14:23:44+00:00https://als-research.org/publication/toward-therapeutic-trials-in-primary-lateral-sclerosis/2025-12-19T14:25:52+00:00https://als-research.org/publication/proposed-research-criteria-for-mild-motor-impairment-as-a-prodromal-syndrome-in-amyotrophic-lateral-sclerosis/2025-12-24T17:55:49+00:00https://als-research.org/publication/design-considerations-for-c9orf72-disease-prevention-trials/2025-12-24T17:57:46+00:00https://als-research.org/publication/identification-of-a-presymptomatic-and-early-disease-signature-for-amyotrophic-lateral-sclerosis-als-protocol-of-the-premodials-study/2025-12-24T17:59:30+00:00https://als-research.org/publication/generation-and-characterization-of-two-pluripotent-stem-cell-lines-from-primary-lateral-sclerosis-pls-patients/2025-12-24T18:10:14+00:00https://als-research.org/publication/multimodal-neuroimaging-guided-stratification-in-amyotrophic-lateral-sclerosis-reveals-three-disease-subtypes-a-multi-cohort-analysis/2025-12-24T18:15:43+00:00https://als-research.org/publication/progressive-and-short-interval-changes-observed-in-the-corticospinal-tract-and-corpus-callosum-of-als-patients-a-texture-analysis-study/2025-12-24T18:14:13+00:00https://als-research.org/publication/measuring-neurofilament-light-in-human-plasma-and-cerebrospinal-fluid-a-comparison-of-five-analytical-immunoassays/2025-12-24T18:12:25+00:00https://als-research.org/publication/skeletal-muscle-biomarkers-of-amyotrophic-lateral-sclerosis-a-large-scale-multi-cohort-proteomic-study/2026-07-13T20:23:35+00:00https://als-research.org/publication/divergent-brain-network-activity-in-asymptomatic-c9orf72-and-sod1-variant-carriers-compared-with-established-amyotrophic-lateral-sclerosis/2025-12-24T18:22:47+00:00https://als-research.org/publication/shared-burden-of-ultra-rare-genetic-variants-across-a-spectrum-of-motor-neuron-diseases/2025-12-24T18:27:17+00:00https://als-research.org/publication/author-response-genetic-associations-with-an-amyotrophic-lateral-sclerosis-reversal-phenotype/2025-12-24T18:25:44+00:00https://als-research.org/publication/isomir-utility-in-amyotrophic-lateral-sclerosis-prognostication/2026-07-13T20:21:56+00:00https://als-research.org/publication/likelihood-based-modeling-of-covariate-specific-time-dependent-receiver-operating-characteristic-curve/2026-07-16T19:18:30+00:00https://als-research.org/publication/a-mutation-in-the-nuclear-speckle-and-splicing-factor-srrm2-is-associated-with-multisystem-proteinopathy-and-causes-dysregulation-of-synapse-associated-genes/2026-07-16T19:20:41+00:00https://als-research.org/publication/longitudinal-plasma-proteomics-predict-phenoconversion-to-clinically-manifest-als/2026-07-27T13:08:15+00:00